Finished
Effect of Magnesium on Dose of Rocuronium for Deep Neuromuscular Blockade
NCT04013243 · Seoul National University Bundang Hospital · Updated 24 Dec 2020
- What is being tested
- Magnesium Sulfate; Placebo
- For
- Magnesium Sulfate Causing Adverse Effects in Therapeutic Use; Neuromuscular Blockade
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 20 years to 80 years. About 68 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 26 April 2019, ends 30 July 2019. Registered 9 July 2019.
- Results
- None posted yet.
In the researchers' words
It is well known that magnesium enhances the effect of neuromuscular blocking agents such as rocuronium. However, it is not known how much magnesium can reduce neuromuscular blocking agents in maintaining deep neuromuscular blockade. Through this study, the investigators will quantitatively analyze the rocuronium saving effect of magnesium.
Sites
- Seoul National University Bundang HospitalSeongnam-si, Gyeonggi-do, South Korea